Today, the U.S. Supreme Court ruled unanimously that the Food and Drug Administration (FDA) followed the law in issuing marketing denial orders (MDOs) for certain flavored e-cigarette products.
Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.
Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).
Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).
The U.S. House of Representatives introduced the Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025. The legislation would reauthorize the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030.
In a new, large national study published today in the Journal of the American Medical Association (JAMA) Network Open, American Cancer Society (ACS) researchers found the 2018 federal policy loosening restrictions on STLD insurance plans was associated with an increase in late-stage cancer diagnoses in states without or with inadequate additional STLD plan regulatory protections.
Today, the American Cancer Society Cancer Action Network (ACS CAN), along with partner organizations, filed an amicus curiae brief with the Supreme Court of the United States (SCOTUS) in the case of Medina v. Planned Parenthood.
Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.
“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.